Interní Med. 2002; 4(6): 297-301

Ischemická choroba srdeční u žen

MUDr. Jana Gandalovičová
II. interní klinika kardiologie a angiologie 1. LF UK a VFN, Praha

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gandalovičová J. Ischemická choroba srdeční u žen. Interní Med. 2002;4(6):297-301.

Článek se zabývá aspekty ischemické choroby srdeční (ICHS) u žen a soustřeďuje se na její odlišnosti ve srovnání s ICHS u mužů co se týče výskytu, symptomů, diagnózy a léčby. Podrobněji se zabývá otázkou hormonální substituční terapie a uvádí výsledky posledních studií zkoumajících účinek této terapie na primární a sekundární prevenci ICHS u žen.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Edwards FH, et al. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 1998; 66: 125-131. Go to original source... Go to PubMed...
    2. Grady D. A 60-year old woman trying to discontinue hormone replacement therapy. JAMA 2002; 287: 2 130-2 137. Go to original source... Go to PubMed...
    3. Herrington DM, et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 2000; 343: 522-529. Go to original source... Go to PubMed...
    4. Hochmann JS, Tamis JE, et al. (for the Global Use of Strategies to Open Occluded Coronary syndromes IIb Investigators). Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 1999; 341: 226-232. Go to original source... Go to PubMed...
    5. Hulley S, Grady D, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-613. Go to original source... Go to PubMed...
    6. Chandra NC, et al. (for the National Registry of MI-I). Observations of the treatment of women in the United States with MI. Arch Intern Med 1998; 158: 981-988. Go to original source... Go to PubMed...
    7. Chun BY, Dobson AJ. The impact of diabetes on survival among people with first myocardial infarction. Diabetes Care 1997; 20: 704-708. Go to original source... Go to PubMed...
    8. Jacobs AK, et al. Better outcome for women compared with men undergoing coronary revascularization: A report from the bypass angioplasty revascularization investigation (BARI). Circulation 1998; 98: 1279-1285. Go to original source... Go to PubMed...
    9. Jacobs AK, et al. Documentation of decline in morbidity in women undergoing coronary angioplasty (A report from the 1993-1994 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). Am J Cardiol 1997; 80: 979-984. Go to original source... Go to PubMed...
    10. Kudenchuk PJ, et al (for the MITI Project Investigators). Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (The MI Triage and Intervention Registry). Am J Cardiol 1996; 78: 9-14. Go to original source... Go to PubMed...
    11. Kwok Y, Kim C, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999; 83: 660-666. Go to original source... Go to PubMed...
    12. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383-390. Go to original source... Go to PubMed...
    13. Mehill J, Kastarti A, et al. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 2000; 284: 1799-1805. Go to original source... Go to PubMed...
    14. NHLBI Web Site. Women´s Health Initiative Hormone Replacement Therapy Study fact sheets. At http://www.nhlbi.nih.gov/whi/hrt.htm.
    15. Roeters van Lennep JE, et al. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 2002; 53: 538-549. Go to original source... Go to PubMed...
    16. Rossouw JE. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res 2002; 53: 550-557. Go to original source... Go to PubMed...
    17. Scirica BM, et al. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). Am J Cardiol 1999; 84: 1145-1150. Go to original source... Go to PubMed...
    18. Stone GW, et al. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 1995; 75: 987-992. Go to original source... Go to PubMed...
    19. Vaccarino V, et al. (for the National Registry of MI 2 Participants). Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999; 341: 217-225. Go to original source... Go to PubMed...
    20. Viscoli CM, et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001; 345: 1243-1249. Go to original source... Go to PubMed...
    21. Wenger NK. Clinical characteristics of coronary heart disease in women: emphasis on gender differences. Cardiovasc Res 2002; 53: 558-567. Go to original source... Go to PubMed...
    22. Zucker DR, et al. Presentation of acute myocardial infarction in men and women. J Gen Intern Med 1997; 12: 79-87. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.